2020
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer
Goldfarb S, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, Bang H, Patil S, Dickler M, Oktay K. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Research And Treatment 2020, 185: 165-173. PMID: 32930927, PMCID: PMC7877450, DOI: 10.1007/s10549-020-05933-7.Peer-Reviewed Original ResearchConceptsAnti-Mullerian hormoneOvarian reserveAdjuvant chemotherapyBreast cancerAMH levelsChemotherapy regimensCompletion of ACSerum AMH levelsAdjuvant tamoxifenAMH recoveryChemotherapy groupPrimary diagnosisBaseline ageMethodsOne hundredAMH assessmentRegimensChemotherapyYoung womenTamoxifenSignificant recoveryCancerMixed effects modelsMonthsTreatment effectsWomen
2013
Fertility preservation in young breast cancer patients: addressing individual patient needs
Rodriguez-Wallberg K, Oktay K. Fertility preservation in young breast cancer patients: addressing individual patient needs. Breast Cancer Management 2013, 2: 135-147. DOI: 10.2217/bmt.12.68.Peer-Reviewed Original ResearchBreast cancer patientsFertility preservationCancer patientsAromatase inhibitorsYoung breast cancer patientsOvarian cortical tissueNumber of oocytesStandard stimulation protocolIndividual patient needsReports of childrenFemale patientsEstradiol levelsMenstrual cycleOocyte freezingBreast cancerPsychosocial distressStimulation protocolNormal rangePatient needsPatientsCortical tissueYoung womenImmature oocytesTamoxifenInfertility
2005
Letrozole and tamoxifen as safer ovarian stimulants in women undergoing embryo cryopreservation for fertility preservation before breast cancer chemotherapy: A prospective controlled trial
Oktay K, Libertella N, Buyuk E, Lostritto K, Vickers A, Akar M. Letrozole and tamoxifen as safer ovarian stimulants in women undergoing embryo cryopreservation for fertility preservation before breast cancer chemotherapy: A prospective controlled trial. Journal Of Clinical Oncology 2005, 23: 539-539. DOI: 10.1200/jco.2005.23.16_suppl.539.Peer-Reviewed Original Research
2004
Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation
Oktay K, Buyuk E, Akar M, Rosenwaks Z, Libertella N. Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Fertility And Sterility 2004, 82: s1. DOI: 10.1016/j.fertnstert.2004.07.007.Peer-Reviewed Original Research
2003
A prospective comparison of tamoxifen alone and tamoxifen-FSH combined protocol for IVF and fertility preservation in breast cancer patients
Oktay K, Buyuk E, Davis O, Veeck L, Rosenwaks Z. A prospective comparison of tamoxifen alone and tamoxifen-FSH combined protocol for IVF and fertility preservation in breast cancer patients. Fertility And Sterility 2003, 80: 63-64. DOI: 10.1016/s0015-0282(03)01973-3.Peer-Reviewed Original Research
2002
Fertility preservation in breast cancer patients: In vitro fertilization and embryo cryopreservation after ovarian stimulation with tamoxifen
Oktay K, Buyuk E, Davis O, Rosenwaks Z. Fertility preservation in breast cancer patients: In vitro fertilization and embryo cryopreservation after ovarian stimulation with tamoxifen. Fertility And Sterility 2002, 78: s80. DOI: 10.1016/s0015-0282(02)03591-4.Peer-Reviewed Original Research